Corvus Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $88 | $0 |
Gross Profit | -29 | -22 | 44 | -20 |
EBITDA | -10,260 | -9,900 | -8,085 | -7,234 |
EBIT | -10,289 | -9,922 | -8,105 | -7,255 |
Net Income | -7,998 | 15,193 | -12,113 | -40,217 |
Net Change In Cash | 0 | 0 | 88 | 0 |
Free Cash Flow | -5,890 | -8,299 | -8,465 | -6,321 |
Cash | 14,691 | 4,999 | 8,740 | 4,680 |
Basic Shares | 77,774 | 75,153 | 68,347 | 66,701 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -85 | -151 | -367 | -460 |
EBITDA | -27,548 | -26,878 | -40,940 | -42,781 |
EBIT | -60,469 | -27,029 | -41,307 | -43,241 |
Net Income | -62,293 | -27,029 | -41,307 | -43,241 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -25,424 | -23,969 | -27,292 | -36,720 |
Cash | 8,740 | 12,620 | 13,159 | 63,458 |
Basic Shares | 60,985 | 48,025 | 46,554 | 41,854 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.10 |
2025-03-31 | -$0.13 |
2024-12-31 | -$0.14 |
